Application

19376086 · USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER

Filed 2025-10-31 · Granted The official file ↗ · Art unit 1622 · Examiner Chris E Simmons Hard · CPC A61K 31/4709 · AVEO Pharmaceuticals, Inc. · Morgan, Lewis & Bockius LLP (BO)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.7 mo

to disposition 8.6 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.